Surgical therapy for dry eye disease

Maria Sampalis, OD, tells Diana Canto-Sims, OD, in this week's episode that the biggest impact AI has made at her practice is when used in the exam room as a scribe for routine patients.

Aldeyra Therapeutics will submit a FDRR to the FDA for reproxalap, an investigational drug or dry eye disease.

An independent analysis of 600 patients across 20 US optometry offices found contact lens wearers generate 29% to 86% higher annual profits than eyeglasses-only patients.

Coats explains how neurotrophic keratitis, Demodex blepharitis, cosmetic habits, and mucus fishing complicate dry eye disease.

The company reported that Acuvue Oasys Max 1-Day and Oasys 1-Day outperformed the other 5 daily disposable lenses evaluated in a recent study, among other Johnson & Johnson data highlights at AAOpt 2026.

Ashraf Ahmad, MD, explains what's driving rising dry eye rates and why eyelid evaluation is often overlooked.

Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, optometry, and retina.

Sharon Fekrat, MD, FACS, FASRS, of Duke University, discusses how retinal imaging fits into the diagnostic picture for CVI, TBI, and neurodegenerative disease, and when eye care professionals should suspect a neurological cause.